Cleerly LABS vs ZEUS System (Zio Watch)
AI Verdict
Choose Cleerly LABS if…
Choose Cleerly LABS if you require a detailed, non-invasive assessment of coronary artery disease, including comprehensive plaque characterization and stenosis quantification, based on a CCTA scan. This tool is ideal for identifying patients at risk for future cardiac events by analyzing plaque volume and type, enabling personalized heart disease management and tracking disease progression.
View Cleerly LABS →Choose ZEUS System (Zio Watch) if…
Choose the ZEUS System (Zio Watch) if you need long-term, continuous cardiac monitoring to detect and characterize intermittent arrhythmias, such as Atrial Fibrillation. This wearable solution is best suited for patients experiencing symptoms like palpitations or dizziness, or those at risk for AFib, where extended ambulatory ECG monitoring is necessary to capture elusive events.
View ZEUS System (Zio Watch) →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Cleerly LABS | ZEUS System (Zio Watch) |
|---|---|---|
| Pricing | Varies | Contact vendor |
| Deployment | Cloud, On-premise | Cloud-based system with a wearable device |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
ZEUS System (Zio Watch)Tool B offers a comprehensive, integrated user experience that caters to both patients and clinicians, featuring a comfortable wearable device, a dedicated patient app for symptom logging and education, and a provider portal/mobile app with seamless EHR integration. While Tool A provides a rich clinician-facing web application with PACS/RIS/EHR integration, Tool B's end-to-end patient and provider engagement tools give it an edge in overall usability.
Clinical Value
TieBoth tools demonstrate significant and validated clinical value in distinct areas of cardiology. Tool A excels in proactive heart attack prevention by precisely characterizing coronary plaque and ischemia from CCTA, supported by studies showing a reduction in heart attacks. Tool B provides highly accurate, long-term detection and characterization of cardiac arrhythmias, particularly AFib, with high physician agreement, crucial for stroke prevention and arrhythmia management.
Pricing & Value
Cleerly LABSTool A provides transparent pricing information, including a retail price, a discounted offer, and details on expanding insurance coverage from major payers, which allows for a clearer assessment of its value proposition. In contrast, Tool B's pricing is listed as 'contact vendor,' making it difficult to evaluate its cost-effectiveness directly.
Enterprise Readiness
TieBoth tools exhibit strong enterprise readiness, being FDA-cleared, HIPAA compliant, and cloud-based with BAAs. Tool A explicitly details its cloud infrastructure on AWS and integration with PACS, RIS, and EHR via an on-site proxy. Tool B also highlights seamless EHR integration, including compatibility with major systems like Epic via Aura, and emphasizes its cloud-based architecture with no on-premise hardware for the core system.
Innovation
TieBoth tools represent significant innovation in their respective fields. Tool A innovates by using AI for comprehensive, quantitative analysis of CCTA to characterize plaque and detect ischemia, aiming to redefine heart attack prevention. Tool B is innovative in its integration of a wearable biosensor with AI for long-term, continuous, and highly accurate arrhythmia detection, advancing remote cardiac monitoring.
Support & Docs
ZEUS System (Zio Watch)Tool B provides more explicit details regarding its support and documentation, including mentions of 'Instructions for Use' for both the system and the watch, a 'Clinical Reference Manual,' and a dedicated EHR integration team. Tool A's available information on specific support channels or comprehensive documentation is less detailed in the provided facts and search results.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Cleerly LABS | ZEUS System (Zio Watch) |
|---|---|---|
| Name | Cleerly LABS | ZEUS System (Zio Watch) |
| Primary Function | AI-powered, FDA-cleared web-based software for comprehensive analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis. | FDA-cleared, AI-powered wearable for long-term continuous cardiac monitoring to detect and characterize Atrial Fibrillation (AFib) and other cardiac arrhythmias. |
| Company | Cleerly | iRhythm Technologies |
| Key Technology/Methodology | AI-powered CCTA image analysis for coronary plaque assessment and stenosis detection. | Wearable biosensor (Zio Watch) for continuous ECG and PPG data collection with AI-powered algorithm for arrhythmia detection. |
| Specific Conditions Detected/Analyzed | Atherosclerosis, stenosis, ischemia (with Cleerly ISCHEMIA module). | Atrial Fibrillation (AFib) and other cardiac arrhythmias. |
| Monitoring/Analysis Duration | Not specified | Long-term continuous monitoring for up to 14 days |
| Reporting/Patient Management | 3D visualization of coronary arteries, personalized heart disease risk assessment, tracking disease progression over time. | Clinically actionable reports, ZioSuiteu00ae portal and provider mobile app for report interpretation and patient management, MyZiou00ae patient app for digital symptom logging. |
Videos
Demos, reviews, and walkthroughs featuring Cleerly LABS and ZEUS System (Zio Watch).
Frequently Asked Questions
More Comparisons
More matchups featuring Cleerly LABS or ZEUS System (Zio Watch)
Backers
Who funded each tool's parent company.